Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ANK-dependent ATP Efflux Causes Calcium Pyrophosphate Deposition in Cartilage

NCT02243631 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT02243631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02243631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ANK-dependent ATP Efflux Causes Calcium Pyrophosphate Deposition in Cartilage
Lead sponsor
VA Office of Research and Development
Phase
Phase 1
Overall status
Completed
Start date
October 15, 2014
Completion date
April 8, 2021
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

calcium pyrophosphate deposition disease